Katrine Bych Kampmann

Title: Katrine Bych Kampmann: Innovator in HMO Production

Introduction

Katrine Bych Kampmann is a prominent inventor based in Valby, Denmark. She has made significant contributions to the field of biotechnology, particularly in the production of human milk oligosaccharides (HMO). With a total of 2 patents to her name, her work is paving the way for advancements in nutritional science.

Latest Patents

Katrine's latest patents focus on the recombinant production of biological molecules in host cells. The first patent relates to a method for the recombinant production of human milk oligosaccharides using genetically modified cells that express proteins from the major facilitator superfamily (MFS). The second patent involves a genetically modified cell designed for the production of oligosaccharides, specifically HMOs, which includes a recombinant nucleic acid encoding a protein from the MFS superfamily.

Career Highlights

Katrine has established herself as a key figure in her field through her innovative research and development efforts. Her work at Glycom A/S has been instrumental in advancing the understanding and production of HMOs, which are vital for infant nutrition and health.

Collaborations

Katrine collaborates with notable colleagues, including Manos Papadakis and Margit Pedersen, who contribute to her research initiatives and help drive innovation within the company.

Conclusion

Katrine Bych Kampmann's contributions to HMO production exemplify her dedication to advancing biotechnology. Her innovative patents and collaborative efforts position her as a leading inventor in her field.